Abstract

BackgroundCataracts and glomerulopathy are disabling complications of diabetes mellitus. The use of medicinal plants in the treatment of diabetes helps prevent or delay these complications. Pterocarpus erinaceus and Amaranthus spinosus are part of these medicinal plants used in traditional medicine to treat diabetes and its complications. The aim of this study was to evaluate in vitro the protective effect of the dried hydroethanolic extracts of the two plants against cataractogenesis and glomerulopathy induced by high glucose. Lenses and kidney fragments from Sprague–Dawley rats were cultured in artificial aqueous humor and in glomerular solution under high glucose, respectively. The extracts of the two plants at doses of 250 and 500 mg/kg bw were added to the culture medium and incubated for 72 h for the lenses and 96 h for the kidney fragments. Morphological and biochemical parameters were evaluated during the cultures.ResultsThe lenses treated with extracts of both plants remained shiny and transparent in contrast to the opacity observed in toxic controls. The treatment by extract caused a significant (p < 0.001) decrease in malondialdehyde and a significant increase (p < 0.001) in glutathione and catalase levels in lenses and kidney fragments. The extracts also caused a significant increase (p < 0.0001) in glucose absorption in glomeruli and a decrease in tubular glucose reabsorption in kidney fragments. This led to a decrease in glucose in the incubation medium.ConclusionThese findings showed that the dried hydroethanolic extract of P. erinaceus and A. spinosus can be used to reduce hyperglycemia effects by inhibiting oxidative stress pathways and then preventing or delaying the onset of cataracts and kidney failure in diabetes.

Highlights

  • Cataracts and glomerulopathy are disabling complications of diabetes mellitus

  • Cataractogenesis Effect of extracts on lens opacity Lenses cultured in ­AAHNormal under 5.5 mM glucose remained bright and transparent until the end of 72 h of incubation (Fig. 1a, b)

  • Lenses cultivated in A­ AHToxic with extracts of P. erinaceus and A. spinosus had a significant (p < 0.01 to 0.0001) decrease in MDA levels compared to the toxic control (TC) (Fig. 2)

Read more

Summary

Introduction

Cataracts and glomerulopathy are disabling complications of diabetes mellitus. The use of medicinal plants in the treatment of diabetes helps prevent or delay these complications. The aim of this study was to evaluate in vitro the protective effect of the dried hydroethanolic extracts of the two plants against cataractogenesis and glomerulopathy induced by high glucose. Our previous study showed that extracts of P. erinaceus stem bark and A. spinosus roots decreased significantly in blood glucose levels in mice and exerted antioxidant activities (Atchou et al 2020). The aim of this study was to assess in vitro the effects of the dried hydroethanolic extracts of the two plants on diabetes complications such as glomerulopathy and cataracts. This study will prove, in addition to the hypoglycemic activity of P. erinaceus and A. spinosus previously reported, the effects of the extracts in the prevention and delay of diabetes complications

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call